Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx

Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx

Introduction<p>The safety concerns of Bruton's tyrosine kinase inhibitors (BTKis) have garnered significant attention due to their severe adverse reactions. However, no existing studies have utilized VigiBase, the world's largest adverse event reporting system, to conduct post-market...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: Han Qu (4391905) (author)
Další autoři: Yuqi Jia (12074459) (author), Zizhen Liu (10067249) (author), Zuan Li (13285615) (author), Xin Zhao (71840) (author), Zhenghua Wu (548294) (author), Guorong Fan (2294386) (author), Yuefen Lou (11843792) (author)
Vydáno: 2025
Témata:
Genetic Immunology
BTKis
FAERS
VigiBase
pharmacovigilance
real world study
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Buďte první, kdo okomentuje tento záznam!
Nejprve se musíte přihlásit.

Podobné jednotky